StacksVerified U.S. regulatory reference

21 CFR §226.20

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
Buildings in which Type A medicated article(s) are manufactured, processed, packaged, labeled, or held shall be maintained in a clear and orderly manner and shall be of suitable size, construction and location in relation to surroundings to facilitate maintenance and operation for their intended purpose. The building shall:
  1. (a)Provide adequate space for the orderly placement of equipment and materials used in any of the following operations for which they are employed to minimize risk of mixups between different Type A medicated article(s), their components, packaging, or labeling:
    1. (1)The receipt, sampling, control, and storage of components.
    2. (2)Manufacturing and processing operations performed on the Type A medicated article(s).
    3. (3)Packaging and labeling operations.
    4. (4)Storage of containers, packaging materials, labeling, and finished products.
    5. (5)Control laboratory operations.
  2. (b)Provide adequate lighting and ventilation, and when necessary for the intended production or control purposes, adequate screening, dust and temperature controls, to avoid contamination of Type A medicated article(s), and to avoid other conditions unfavorable to the safety, identity, strength, quality, and purity of the raw materials and Type A medicated article(s) before, during, and after production.
  3. (c)Provide for adequate washing, cleaning, toilet, and locker facilities.